Home Alemtuzumab Group Members Research For People with MS Contact News
© Website designed by Alasdair Coles, 2012
NEWS YOUR HEADING TEXT Alasdair Coles, Joanne Jones and Alastair Compston  Cambridge Neuroimmunology

Information for people with MS

We endorse the information on these websites: the MS Society website. the MS Trust website Shift MS is a social network site for people with MS. A blog on MS research from colleagues in London

Clinical Trials in Multiple Sclerosis

Trials in the US, and many in the EU, are listed at the US Clinical Trials website Clinical Trials in Cambridge are listed here

Alemtuzumab

Alemtuzumab is now licensed for the treatment of multiple sclerosis and apporved by NICE, for use in the NHS. It should soon be available at a hospital near you. We are currently running a trial of alemtuzumab for people with relapsing-remitting multiple sclerosis, based in Cambridge, UK. In this trial, everyone receives alemtuzumab. Half also receive an experimental drug. Further information is here.